missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ EEF2 Monoclonal Antibody (5B6)
Description
MA5-15833 targets EEF2 in indirect ELISA, IF, IHC, and WB applications and shows reactivity with Human samples. The MA5-15833 immunogen is purified recombinant fragment of human EEF2 expressed in E. Coli. . MA5-15833 detects EEF2 which has a predicted molecular weight of approximately 95kDa.
Catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome.
Specifications
Specifications
| Antigen | EEF2 |
| Applications | ELISA, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Monoclonal |
| Clone | 5B6 |
| Concentration | Conc. Not Determined |
| Conjugate | Unconjugated |
| Formulation | ascites with 0.03% sodium azide |
| Gene | EEF2 |
| Gene Accession No. | P13639, P58252 |
| Gene Alias | EEF2; EEF-2; Ef2; EF-2; Elongation factor 2; elongation factor-2; eukaryotic translation elongation factor 2; I79_013848; polypeptidyl-tRNA translocase; SCA26; zef2 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?